Nanotechnology Applied Animal Nutrition - PowerPoint

W
Description

Nanotechnology Applied Animal Nutrition document sample

Shared by: txr21190
Categories
Tags
-
Stats
views:
277
posted:
4/20/2011
language:
English
pages:
57
Document Sample
scope of work template
							    Agrifood Nanotechnology:
Science, Technology, and Society

                   Prof. Jennifer Kuzma
    Center for Science, Technology, and Public Policy
      Humphrey Institute, University of Minnesota

    James Romanchek, Adam Kokotovich, and Peter VerHage



                    AARI Meeting 3-1-07
                    Outline
Why agrifood nanotechnology?

Areas and products of agrifood nanotechnology

U.S. Agrifood nanotechnology R&D—an analysis

Case studies of emerging oversight issues

Thoughts on collaborations and initiatives
                  Why Agrifood Nanotechnology?
               Holds promise for more sustainable and safer methods of food and fiber production
       Lots of potential applications, a few on the market, but currently, little attention to oversight issues



Challenges:                                                       Lessons (AgBiotech) :

   Little information about R&D, safety,                               Need for transparency in product
   and products in the public domain                                   review and oversight process
   (CBI, IPR)
                                                                       Need for regulatory clarity and holistic
   Overlapping or missing jurisdiction for                             approaches to convergence products
   products? (e.g. premarket testing)
                                                                       EU vs. US position on GEOs in food
   Food and humans have a special                                      and agriculture
   relationship tied to necessity, culture,
   and environment.
                                                                       First generation of GEOs in food and
   Distribution of risks and benefits are                              agriculture had few benefits to those
   often different than for medical                                    who bore any potential risk
   applications
                                                                       Generally more talk and acceptance of
   Time for independent study of                                       the need for public information and
   oversight models for agrifood                                       dialogue early and often
   nanotechnology –how & who?
Selected Categories of Nanotechnology Applied to Food and Agriculture
               Agriculture Bio-Energy      Single molecule detection to determine enzyme/substrate
                           or Products     interactions (e.g. cellulases in production of ethanol).
                                           Materials from biomass

                           Agrochemical Delivery of pesticides, fertilizers, and other agrichemicals
                           Delivery     more efficiently (e.g. only when needed or for better
                                        absorption).

                           Animal          Delivery of growth hormone in a controlled fashion.
                           Production
                                           Identity preservation and tracking.

                           Animal or       Detect animal pathogens, such as foot and mouth disease
                           Plant Health    virus. Detect plant pathogens early.

                           Animal          Deliver animal vaccines.
                           Medicine

                           Plant           Delivery of DNA to plants towards certain tissues (i.e.
                           Production      targeted genetic engineering).

               Food        Sensing         Detect chemicals or foodborne pathogens; biodegradable
                                           sensors for temperature, moisture history, etc.

                           Safety          Selectively bind and remove chemicals or pathogens.

                           Packaging       Prevent or respond to spoilage. Sensing features for
                                           contaminants or pathogens.

                           Healthy Food Better availability and dispersion of nutrients,
                                        nutraceuticals, or additives.
 Kuzma, 2006
            Food-related Nano-Products on Market
                  Project on Emerging Nanotechnologies consumer inventory
                                  www.nanotechproject.org



                                                      Micelles for functional food
Storage of food with Ag antimicrobial

                                                      Refrigerator with antimicrobials
Cocoa delivery with little sugar

                                                      Glycerin micelles to remove
Cooking Oil Quality--nanoceramic
                                                      pesticides

Nanoclay barriers to O2 and CO2
                                                      Several dietary supplements
    Emerging products for tracking
•FoodExpert-ID DNA chip—bioMérieux, France


•80,000 oligonucleotide probes synthesized
onto a glass surface using photolithography.

•specific vertebrate cytochrome b genes

•identification of animal species in sample

•Traceability of food and feed




                                               •Nanobarcodes , Nanoplex Technologies, USA

                                               •Supply chain tracking
                    Guiding Principles
               What Do People Care About?

                                                   Focus groups participants
People do not care only about the                   generally positive about promise
   number of deaths and injuries.                   of nanotechnology and majority
                                                    did not support a ban.

They also care about                               ―Food and Nutrition‖ 5th most
- Equity**                                          frequently named benefit (6%)
- Controllability**
- Voluntary or involuntary exposure**              ―Food and Food Chains
                                                    Concerns‖ 6th on concern list (7%)
- Time Frame: Immediate or delayed**
- Intergenerational effects
                                                   Mandatory oversight and access
- Nature and extent of Knowledge**                  to information important to the
                                                    majority
-   (multiple works of social psychologists,
    P. Slovic, Decision Research, and B.       Macoubrie, J. 2005 (Project on
    Fischoff, CMU)                             Emerging Nanotechnologies)
         Anticipatory Governance
                       Science, Risk, Society



                       EHS:
                       Health/environmental risk
                                                      Large Societal changes
          Worker Safety
Technology funding, development, incentives      Human rights
        Norms, standards        Social/Ethical




     Near                               Medium                             Long
             Bottom Up Methods
     Agrifood Nanotechnology Oversight
Phase 1*: Start with individual
products                               Research Topics
   Inventory and assessment of R&D    Research Techniques
    in nanotechnology as applied to    Estimated time to commercialization
    food, agriculture, and             Part of food or product supply chain
    agroecosystems                     Endpoints of exposure
                                       Qualitative risk/benefit ranking
Phase 2:* Select individual products
  Selection of case studies and
   qualitative risk/benefit issue
   identification

Phase 3:* Assess individual
products, extrapolate up
   Analysis of regulatory or non-
    regulatory governance systems
    for agrifood applications
     Methodology for inventory
Public databases and websites
    Nano and food or agriculture as search terms
    USDA-CRIS, PTO, EPA, NIH, DOE, DOD, DHS, NSF
    2000-Fall 2005

Adjusted USDA categories for research, techniques, and topics as
specified in 2003 report, Nanoscale Science and Engineering for
Agriculture and Food Systems.

Own criteria for other categories, such as type of research, time to
commercialization, qualitative risk/benefit ranking, exposure
endpoints, sectors in the food supply continuum

160 projects were found
121 entries were sent to PIs for review
Agrifood Nanotechnology Inventory
 Limitations

     Not focused on industrial or consumer products

     Stopped searches in Dec. 2005—needs updating on a regular basis

     Publicly available information
          No investigative reporting

     Categorization based on available information and PI knowledge/experience
          Reviewed by PIs positively, but limited response (14%)

 Strengths

     Good start to getting compiled information, analysis, and dialogue in public
      domain

     Independent analysis (e.g. PIs have no vested interest in this topic, such as
      stock holdings, products being developed, ties to agencies, etc,)
Key Results of Agrifood Inventory
Large focus on food packaging and
sensing for foodborne pathogens

Focus on retail and consumer
applications

More of a focus on health than
environmental benefits. But significant
proportion on environment/ag waste

No ―high risk‖ projects, according to
our criteria of toxic materials under
widespread use

Most projects applied, and projected to
be commercial in 5-15 years.

Database can be mined in various
ways to focus EHS research
Techniques for Projects
Topics for Projects
USDA Research Areas
Stage and Type of Work
Sector of Food Supply Chain
Endpoints of Exposure
Risk and Benefit Qualitative Ranking
Mining the Database to Focus EHS research
      Other ways to mine database
      Particles of interest                          Private vs. public
160
140
                                                            20   2 5           EPA
120                                                    15                      NIH
100                                                                            USDA
 80                                                                            PTO (ind.)
                                                       28                 90   PTO (univ)
 60
                                                                               NSF
 40
 20
  0
                                         )
           )


                       )




                                                 l
                                        )
                                      (5




                                               ta
                     (4
        (4




                                      (2

                                             To
                                   NT
                 2
     er




                                    s
                 O




                                  ne
  lv




                           C
               Ti
Si




                                re
                             lle
                           Fu
       Regulatory Unknowns for Food and Agricultural
                        Products

          CPSC                                  Consumer Products
                                                                                                   No pre-market
                                                                                                   testing

                                                                                                   Pre-market
            EPA                                                                                    testing possible
                                   Chemicals/Particles

                                                                                                   Pre-market
                                                                                                   testing required
         OSHA                               Manufacturing
                                                                                                   Lack of
                                                                    Drugs/biologics                guidance
                                                  Devices




           FDA

                  Cosmetics


          USDA                                                      Agricultural products
                                 Food



                    TODAY        2006                                                       2010

Adapted from E. Michelson,WWIC
             Bottom Up Methods
     Agrifood Nanotechnology Oversight
Phase 1*: Start with individual
products
   Inventory and assessment of
    research and development in
    nanotechnology as applied to
    food, agriculture, and
    agroecosystems
                                       •   Criteria for case selection:
Phase 2:* Select individual products   •   Frequency of topics and techniques in
                                           database
  Selection of case studies and       •   Sector of supply chain
   qualitative risk/benefit issue      •   Exposure endpoints
   identification                      •   Oversight relevance

Phase 3:* Assess individual            •   Research Methods:
products, extrapolate up               •   Literature searches—Toxnet, Fed Reg, etc.
                                       •   Researcher inquiries
   Analysis of oversight systems
                                       •   Case study comparison approach
    and issues for selected agrifood
    applications
               Case Study #1
   Agroecosystem—Environmental application
       Using Nanotechnology to identify and characterize hydrological flowpaths in
       agricultural landscapes (Walter, et al. Cornell University)

       Encapsulated DNA and PCR detection--use the vast diversity of DNA sequences for
       finer resolution of flows in order to address non-point source pollution




. Photo from Quinn et al. http://www.ncl.ac.uk/wrgi/TOPCAT/TCTheory.html
                Case Study #1
            Risk & Oversight Issues
Risk Issues                                     Oversight Issues

Capsule                                         Broad range of statutes
    Generally non-toxic                            TSCA, CWA, FIFRA, etc?
    PLGA-chitosan used in drug-delivery
    Dissolve in water
                                                Lack of certainty about convergence
    However, not tested at large scale         applications
     environmental release
                                                    Nano-bio-environment
Fate and transport in environment
    Information needed                         Detection capabilities
    PIs are conducting this work in phase II       For large scale release?


DNA                                             Societal
    Uptake by microbes?                            Public perception and concern about
                                                     large scale release of DNA in the
    Persistence and fate in environment?            environment
    Usually degraded
               Case Study #1
                Conclusions
Relatively ―easy‖ to find information on nature of particle
and researchers’ plans (transparent)

High degree of uncertainty as to regulatory system &
statutes

Research needs on fate and transport of PLGA and
DNA—project included some of these elements

High potential for public concern in watershed areas—
perception of DNA released into environment
Case study 2: On-farm plant production
Nano-and Micro-encapsulation of Agrochemicals –
SBIR Phase 1, LNK Chemsolutions
1-Naphthalene Acetic acid (NAA, the target agrochemical) in chitosan

Timed release of agrochemicals, lesser amounts




                   Marie, et al. Biomolecules, 2002, Chitosan nanocapsule
                  Case Study #2
              Risk & Oversight Issues
Risk Issues
                                              Oversight Issues
Capsule--chitosan
   Generally non-toxic                       Clear Statute—FIFRA
   Many toxicity studies found                   Nano-scale formulation evoked?
   However, not tested at large scale
    environmental release                     Social Issues
                                                  Special attention and concerns related
Fate and transport in environment                  to nano-scale formulation of commonly
    Information needed                            used substances?
    Not clear if it is being funded              General perceptions of pesticides in
                                                   the environment
NAA—plant growth regulator
  Toxicity studies at macro level indicate
   human nasal, skin, and severe eye
   irritant
  Effects on animals include CNS
   depression, decreased live births, birth
   weight, and infant survival
  Data submitted to EPA for registration
  Exemption for food tolerance under
   FQPA
                 Case Study #2
                  Conclusions
Relatively ―easy‖ to find information on nanoparticle as components
are both already used in drugs and agriculture

High degree of uncertainty as to whether regulatory system &
statutes would give attention to the ―nano‖ scale

Research needs on fate and transport of chitosan (and NAA?) in
environment

Research needs on health effects at nanoscale—FQPA exemption?

Public generally concerned about agrochemicals, but what concerns
would the nano-version trigger? (UPE)
         Case Study #3—Food additives
Nano-and Micro-encapsulation of Food Additives
SBIR Phase 1, LNK Chemsolutions
Gum arabic/maltodextrin formulation for the shell of citral capsules

Timed release of nutraceuticals that inhibits bacterial growth and imparts lemon flavor
Capsule restricts the diffusion of air and dissolves readily
                     Case Study #3
                 Risk & Oversight Issues
Risk Issues
                                           Oversight Issues
Capsule
                                           Clear Statute—FFDCA
  GRAS
                                              GRAS or food additive?
  Only harmful when animals
   overfed—no carcinogenic effects            Micro-level citral GRAS
                                               DSHEA if not in food-supplement
  No nano encapuslation toxicity
   studies, however
                                           Social Issues
Fate and transport in environment             Consumer knowledge of risks and
   Information needed                         benefits of encapsulated citral at
                                               nano scale
   Not clear if it is being funded           Labeling
                                              Post-market monitoring
Citral
    Micro encapsulated citral shown       Transparency in safety process
     to have negative effects for animal
     feeding studies                          Industry does testing
    Malignant lymphoma                       FDA relies on industry ―nano‖
    Liver and fore-stomach damage             claims
                 Case Study #3
                  Conclusions
Relatively ―easy‖ to find information on nanoparticle as components
are both already used in food and dietary supplements

High degree of uncertainty as to whether regulatory system &
statutes would give attention to the ―nano‖ scale

Research needs on health effects at nanoscale—is citral GRAS,
especially at the nanoscale?

Pre and post market safety evaluation given citral effects

Consumer rights to know—labeling of nano-particles in food
  Case study #4—biobased consumer and
             medical products
 Cellulose Nanocrystal Composites (Simonsen, OSU)
 Stronger than steel or alumium




AFM image of cellulose nanocrystal film, Simonsen, http://woodscience.oregonstate.edu/faculty/simonsen/
               Case Study #4
           Risk & Oversight Issues
Risk Issues                             Oversight Issues

Cellulose nanocomposites                Clear Statute for device use
    Diffusion out of matrix?               FFDCA and medical device
                                             amendments
    Microcrystals—no observed effect       Will nano composites in devices by
                                             considered as new or under class I or II
                                             PMN and 510k?
Fate and transport in medical product
   Diffusion out of filters for
    hemodialysis?                       WHO ―precautionary approach‖ to
                                        crystals under 5 um
                                            Limit content of particles under this size
Blood toxicity                              ADI not specified
    Cross blood-CNS barriers?
                                        Social Issues
For non-medical product                    Medical community informed
    Life cycle issues                      about nanoscale particles
    Environmental pros and cons            embedded in matrix?
                                           Patients informed?
                                           Acceptable level of risk versus
                                            medical benefit of improved
                                            dialysis?
                                                  Who decides?
                   Case Study #4
                    Conclusions
Relatively ―easy‖ to find information on nanoparticle as components used in
materials

Research needs on nanocellulose diffusion out of matrices

Research needs on health effects at nanoscale—is micro and nano scale
cellulose of concern?

FDA might not consider nanocellulose in devices as a novel device—Class I
or II
International harmonization—WHO taking ―precautionary approach‖

Patient/doctors ability to know—enough information to determine what risk
is acceptable for them vs. the medical benefit

Life cycle analyses of production of nanocellulose and environmental
benefits-risks
      Case study #5—Animal production & food
                     safety
        Adhesin-specific Nanoparticles for removal of pathogens from livestock
        *Latour et al. Clemson University
        Block bacterial colonization in guts and remove these important human
        pathogens on the farm

                                                                   Nanoparticles
                                                                   bind and block
                                                                   this interaction




   . Photo from Dr. Gary E. Kaiser,
http://student.ccbcmd.edu/~gkaiser/goshp.html
                           Case Study #5
                       Risk & Oversight Issues
Risk Issues
                                           Oversight Issues
Use of polyethylene glycol for delivery
    PEG shown to be safe                  Difficult to find information on the
    No effect on cell death and do not    nanoparticle
     activate immune response                   Intellectual property issues
    Nano version effects not known
                                           Statutory authority and exercise by
Weigh any potential risk with benefit of   agencies unclear
reduction of antibiotics important for        CWA and CAFO for animal
human health                                   waste?
                                              FFDCA—NAD?
Targeting molecule                            FDA--Feed additive or GRAS?
    Mannose for E. coli                      Agency’s Feed Safety System
    Effects on other helpful gut flora
                                              USDA (VSTA)

On farm use                                Social
    Effects on environmental flora           Risk perception
    Animal waste streams to water            Trust in ag industry
                                              Antibiotics and/or hormones in
                                               meat?
                    Case Study #5
                     Conclusions

Not very easy to find information on nanoparticles, as intellectual
property rights sought

Regulatory uncertainty—convergence-type product

Trust and independence of communicators
    Benefits of antibiotic reduction—human health benefits
    Perception of ―antibiotics or hormones‖ in food


Research needs on environmental issues with nanoparticles in
animal waste
Case Study #6—Food quality and safety in
         retail and consumption
―Nanoclays‖ in food packaging materials—barriers to O2 and CO2
Silica, silicite, clay,organomontmorillonite, calcium carbonate




           Picture from CSIRO http://www.cmit.csiro.au/brochures/tech/nanotech   /
                Case Study #6
            Risk & Oversight Issues
Risk Issues                                  Oversight Issues

Clay nanoparticles toxicity                  Statutory authority clear—FFDCA
    Macro versions non-toxic
                                                Food Contact Substances
    Nano versions more reactive, and what
     does this mean for toxicity?               (Food additive or GRAS if there is
                                                 a substance in packaging that is
                                                 intended to migrate to food)
Nanoparticle migration out of matrices
    Lack of research
    Migration likely low                    Most now go through Notification
                                             Process now (FCN)
                                                No data requirements
When composites contain                         Ag in packaging has gone through
antimicrobials, detection molecules,             this process
etc. there will be additional risk issues
    Ag in food packaging                    Social Issues
                                                Transparency &Trust
Life cycle issues with manufacturing            Many FCS with nanoparticles on
                                                 market,
                                                Public unaware and safety studies
                                                 not available
                 Case Study #6
                  Conclusions

Many patents, and compositions of marketed products can be found,
but not easily (I.e. no FDA website of nanopackaging materials and
data submitted, and FCN)

Transparency and public trust/consumer knowledge

Regulatory mechanism clear, but questions as to whether FDA
would be likely to invoke the petition and threshold process for
nanocomposites

Research needs on environmental issues with nanoparticles during
manufacturing—high volume application (TSCA, RCRA, etc.)
     Key ―attention‖ areas—importance of issue type
                            a work in progress… ++= 5 to -/+=1?
                         other issue areas like COI in safety studies?

Case study          Data-risk    Regulatory    Transparency      Public       Socio-     Potential
                    gaps         Unknowns                        reactions/   economic   benefits
                                                                 attitudes    impacts
1)Agroecosystem     +            ++            -/+               ++           -/+        +
particles

2) Plant            ++           + (nano) +                      ++           +          +
production
particles
3) Food             ++           + (nano) +                      +            +          +/-
enhancement
particles
4) Composites for   +            + (nano) +                      -/+          +/-        +
non-food product
(e.g. medical)
5) Animal           +            ++            ++                ++           -/+        ++
husbandry
particles
6) Composites for   +            +/-           +                 +/-          +          +
food packaging
             Anticipatory Governance
                                                                Integrate natural science and
  Identify and address regulatory and non-                      engineering investigations with social
  regulatory oversight issues associated                        science and policy research from the
  with new technological products long                          outset—Guston and Sarewitz, ASU
  before they are marketed so that system
  is prepared—Kuzma et al., UMN
Upstream Oversight Assessment                              Real Time Technology Assessment



                                       UOA                       RTTA




                                  UPE--Upstream Public Engagement


                            McNaughten, Willis, Wilsdon, Wynne, Marris, et al.
              Future Work
Polish case study analysis

Use of case study analysis for
   Expert judgment solicitation
   Upstream public engagement
   Discussions with decision makers

Collaborations with social scientists and
others on this approach
        Comprehensive Study of Oversight Policy


                                                          Public Policy
                                           Practical       Analysts
                                              S&T
                                                                 Political           Other
Scientists Technology                    Policy Wonks
                                                                Scientists          Fields?
           Developers     Risk      Regulatory
                        Assessors                                                   Input?
                                      Policy
                                     Makers
                           Regulatory                          S&T
                           Assessors                          Studies
                         (CBA focused)     Lawyers

                                                         Social              Historians
                                         Academic                         And Philosophers
                                         Legal          Scientists
                                                                             of Science
      Communication Social               Studies
         Experts   Psychology                                        Ethicists



           Who is thinking about oversight in a comprehensive way?
                        My thoughts
Begin initiatives and collaborations with the end in mind
    Delicate balance between basic, applied, and developmental research

    Within applied research, balance between ―products that would be nice‖ and
     solving societal/national problems (energy, clean water, health, safe food, etc.)
         South African model?

    Match applications with implications research because…

    Desired ends are consumer and stakeholder acceptance and trust

    Trust is affected by not only safety, but also transparency and participation

    Employ upstream oversight assessment and other anticipatory governance
     approaches

Unique, and in the long run, most successful
    goals of better and safer products, sustainability, economic and industry growth,
     social and environmental well-being, and justice.
      Questions & Input?
                      Prof. Jennifer Kuzma
                         612-625-6337
                      kuzma007@umn.edu
              http://www.hhh.umn.edu/centers/stpp



Funding sources:
Project on Emerging Nanotechnologies
Consortium on Law and Values in the Health, Environmental, and Life
Sciences—U of MN
NSF NIRT ―Evaluating Oversight Models for the Nano-bio Interface‖
(2006-2010)
Extra slides if needed/desired
                    If so, How?
       Top-Down Approach to Study Oversight for
                  Nanotechnology

  Multiple methods used, multiple criteria assessed, multiple
  disciplines and experts involved

  Phase 1—Evaluation of 6 historical oversight models, all relevant to
  nano-bio interface
      Drugs, Devices, Gene Therapy, GEOs in food and agriculture,
       Chemicals in the Environment, Chemicals in the Workplace

  Phase 2—Mapping lessons to nano-bio

  Phase 3—Testing lessons in scenarios for specific nano-bioproducts


Funded by the NSF, $1.2 M NIRT, co-PIs, Wolf, Kuzma, Paradise, Ramachandran, and Kokkoli
                                   Phase 1: Integrated Oversight Assessment (IOA)
                                                for Historical Models




            How was the
                                                        What are its                       What are
            oversight model
            developed?                                  Attributes?                      the outcomes?




                                           Common Scale and Correlations?
                                                DRAFT criteria for attributes:            DRAFT criteria for outcomes:
DRAFT criteria for development:
                                                •Dealing with uncertainty                 •Expert, developer and consumer
•Impetus--driving force (e.g. public concern)
                                                •Accountability                           satisfaction or confidence in
•Stakeholder input
                                                •Feedback loops/Post market monitoring    system
•Outside Expert input
                                                •Transparency: access to information      •Flexibility for different cultures or
•Empirical risk/benefit studies
                                                •Mandatory or voluntary                   ethical framework
•Reactive or proactive
                                                •Actors involved                          •Choice of consumers
•Opportunities for ―values‖ discussions
                                                •Ease of navigation for developers        •Effects on industry structure
•Etc.?
                                                •Opportunities for public input           •Effects on innovation
                                                •Institutional structure and cultures     •Adverse event reported
                                                •Data requirements                        •General perception of product
                                                •Who conducts safety tests?               safety
                                                •Etc.?                                    •Number of products approved
                                                                                          •Time and monetary costs to
Multiple Methods to Assess Criteria                                                       bring product to market
                                                                                          •Etc?
                            Techniques
Transport processes—nanomaterials as agents for transporting chemicals,
molecules, etc.

Bio-selective surfaces—nanomaterials with enhanced or reduced ability to bind or
hold specific molecules and/or organisms.

Bio-separation—nano-materials or -processes with ability to separate molecules,
biomolecules, or organisms.

Microfluidics/MEMs—liquid streams used to separate, control, or analyze at the
nanoscale. They might have special flow properties at this scale.
Microelectromechanical systems (MEMs) are also included here. They are devices
with channels and wells, electrodes for detection, connectors, and fluidic input/output
ports.

Nano-bioprocessing—use of nanoscale technology and/or biological processes to
create a desired compound or material from a defined stock. The product itself may
be bulk or nanoscale.

Nucleic acid bioengineering—use of DNA as building blocks to form nano-particles or
use of nano-particles for genetic engineering.

Drug delivery—use of nanoparticles or nanomethods to deliver drugs to animals.

Modeling—use of nanotechnology to build models of systems, or the modeling of
nanoparticles in systems.
                                      Topics
Biosensors—use of nanotechnology for sensors based upon biological processes or biological
molecules, or for detection of biological molecules, processes, or organisms.

Environmental processing—use of nanotechnology for studying environmental phenomena, removing
contaminants in the environment, or remediating/reducing waste. Study of nanomaterials in the
environment too.

Sustainable agriculture—use of nanotechnology for reducing agricultural inputs or outputs that can harm
the environment or human health (e.g. pesticides) or are in short supply (e.g. water); or for making
products from agriculture in a sustainable way.

Pathogen detection—use of nanotechnology to detect pathogens in surroundings, organisms or food.

Plant/Animal Production—use of nanotechnology to improve the cultivation of plants or animals,
including via transgenics or cloning.

Veterinary medicine[1]—use of nanotechnology to improve animal health and/or the safety of animal
derived foods.

Bioprocessing for food—use of nanotechnology for better food processing or quality.

Nano-bioindustrial products—use of nanotechnology for developing industrial products from agriculture
or its by-products.

[1] Not in USDA Nanoscale Science and Engineering 2003 Report.
            USDA Research Areas
Pathogen and Contaminant Detection—pathogen or contaminant detection in agriculture, food, or the
environment.

Identity Preservation and Tracking—systems that provide producers, processors, and customers with
information about the practices and activities used to produce a particular crop or agricultural product. Also,
provide information on the origin and movement of crops, animals, or products.

Smart Treatment Delivery Systems—delivery of molecules in agricultural production or processing in time-
controlled, spatially targeted, regulated, responsive, or other precise ways. Also, systems could have the ability to
monitor effects of delivery.

Smart System Integration for Agriculture and Food Processing—integration of a working system with
sensing, reporting, localization, and control. System could be used anywhere along farm to table continuum, or at
multiple points.

Nanodevices for Molecular and Cell Biology—devices based on or applied to molecular and cellular biology
that separate, identify, study, modify, or sense.

Nanoscale Materials Science and Engineering—development of novel materials through materials science and
engineering. Work to better understand the behavior and properties of nanomaterials.

Environmental Issues and Agricultural Waste—study of nanoparticles in the environment, such as in the
transport and bioavailability of nutrients and pollutants. Understand transport and toxicity of nanoparticles in
agricultural pollutants. Nanotechnology applied to environmental or waste issues.

Educating the Public and Future Workforce—education about nanotechnology and nanoproducts; studies on
ethical and social issues (cited in USDA report, although not reflected in USDA’s short title of this research area);
infrastructure support; technology transfer support; public understanding of risks and benefits.
      Type of Research and Time
              Categories
Type of Research:

Development—specific product cited, largely experiments or studies to optimize product
Applied—specific application noted, but may also lead to better understanding
Basic—fundamental understanding is goal, specific application not stated (although there could
be one in the future)

Time to Commercialization:

0-5 years –applied/development projects which directly address regulatory or product optimization
issues. The applications of the work appear to be very near- term with minimal regulatory
concerns, or they are already in the marketplace and properties are being studied or optimized.
5-10 years –applied/development research that is based upon proven technology and for which
there are not serious safety concerns
10-15 years—applied research that is in the early stages of concept or development
15-20 years—applied/basic research for which applications are not specified, but they can be
envisioned.
20-50 years—basic research for which few, if any, applications are envisioned, but for which
fundamental knowledge will eventually lead to some.
     Food Supply Chain Sector
Agroecosystems—application for or research on agricultural systems, and/or on
surrounding natural systems.

Pre-harvest—application or research on the farm or in the forest, during
agricultural production.

Transportation—application or research dealing with transporting agricultural or
forest raw commodities or products from the farm to the processor or retailer.

Post-harvest—research or application after harvest, at the stage of processing
the commodity or product

Retail—research or application dealing with storage, display, etc. at the place
where the product is sold.

Consumer—research or application dealing with the consumer end, such as
storage and use of agricultural products in the home. Also, this category is used
for research which primarily improves the quality of the end product (e.g. better
taste).

Post-consumption—research or applications for after the product is consumed.
For example, for food safety illness detection.
Possible Exposure Endpoints for
       Potential Products
Lab workers—most nanomaterial or particles are made or studied in the lab at some point. In most cases,
lab workers will be exposed. The study of naturally-occurring nanoparticles would be a case in which
this box would not be checked.

Farmers—farmers are exposed if the nanomaterial, particle, or method is being used on the farm.

Ecosystems—ecosystems are exposed if the nanomaterial is used 1) on the farm (animals and plants on
the farm, or the farm agroecosystem) or 2) for wide environmental applications, or 3) if it is not disposed
of properly. We assume that material used in manufacturing or the lab is disposed of properly. So, if this
box is checked, it is because the material is intended at some point for environmental release.

Industry Workers—industry workers will be exposed during production, manufacture, transport,
processing, or at the retail/distribution stage.

Consumers—if consumers will likely come in contact with the material, this box is checked. The
applications are either intended for consumer products or are left in the material as a result of production
or processing.

Others—in some cases, there might be sub-populations that are specifically exposed as a result of the
application or research.

Unknown—this box is checked when the description of the project is too vague, or the applications are
too broad to determine who will be exposed.
                     Risks and Benefits
Environmental/Ecological Risks or Health Risks            Environmental/Ecological or Health Benefits

Low                                                       Low
If exposure to humans, animals or the environment         Application or research not meant to improve
is minimal and the particles are generally non-toxic,     human or animal health, or the environment.
we categorize the risk as low.
                                                          Medium
Medium                                                    Application or research might improve health, or the
If exposure to humans, animals or the environment         environment, but not explicitly developed for that
is minimal OR the particles are generally non-toxic       purpose or for addressing a great societal problem.
we categorize risk as medium. In this category,
there are relatively benign particles that are widely     High
used in food and agriculture. Likewise, a toxic
particle that is meant to stay in the lab or processing   Application or research specifically developed to
plant could also be in this category. In the cases of     address an important societal need for improving
nanotechnology applied to biobased products,              health or the environment.
―medium‖ was used for environmental or ecological
risks with the question of whether harvesting and
processing are done in a sustainable way (i.e. life
cycle issues).

High
Exposure to humans, animals or the environment is
widespread and particles show toxicity or are
expected to be toxic.

						
Related docs
Other docs by txr21190
Mystery Shopper Subcontractor Agreements
Views: 156  |  Downloads: 0
Nanotechnology and Business
Views: 2  |  Downloads: 0
Nanotechnology in Tissue Engineering
Views: 178  |  Downloads: 0
N.J. Unclaimed Funds
Views: 108  |  Downloads: 0
N.J.S.a. Statute of Frauds - DOC
Views: 24  |  Downloads: 0
Nafta Certificate of Origin Xls - PDF
Views: 327  |  Downloads: 0
Nar Buyer Representation
Views: 8  |  Downloads: 0